By Sheri Kasprzak
New York, Dec. 19 - Oragenics, Inc. said it has settled its previously announced private placement for $1,174,800.
The company issued 2,937,000 shares at $0.40 each to a group of individual investors.
The investors received one warrant for every share purchased, exercisable at $0.60 apiece.
The deal was first announced Nov. 21 as a $1.2 million offering of up to 3 million shares under the same terms.
Proceeds will be used for clinical development of the company's technology and for general corporate purposes.
Based in Alachua, Fla., Oragenics develops antibiotics used to prevent cavities.
| Issuer: | Oragenics, Inc.
|
| Issue: | Stock
|
| Amount: | $1,174,800
|
| Shares: | 2,937,000
|
| Price: | $0.40
|
| Warrants: | One warrant per share
|
| Warrant strike price: | $0.60
|
| Announcement date: | Nov. 21
|
| Settlement date: | Dec. 19
|
| Stock price: | $0.60 at close Nov. 21
|
| Stock price: | $0.53 at close Dec. 16
|
|
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.
